search
Back to results

Abdominal Massage for Bowel Dysfunction (AMBER)

Primary Purpose

Multiple Sclerosis

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Abdominal massage
Optimised bowel care
Sponsored by
Glasgow Caledonian University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple Sclerosis focused on measuring Multiple Sclerosis, Neurogenic Bowel Dysfunction, Abdominal massage

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male or female over the age of 18 years;
  • Diagnosis of MS (in a stable phase i.e. no MS relapse for 3 months);
  • No major change of medication for 1 month e.g. introduction of disease modifying medications;
  • Individual is bothered by their bowel dysfunction, and;
  • Must not have used abdominal massage for at least 2 months.

Exclusion Criteria:

  • Individuals who are unable to undertake the massage themselves or do not have a carer willing to do it;
  • Individuals who are unable to understand the study processes;
  • Individuals who have contraindications to abdominal massage e.g. history of abdominal/pelvic cancer, hiatus, inguinal or umbilical hernia, rectal prolapse, Inflammatory Bowel Disease, pregnancy and past history of volvulus.
  • Recent abdominal scars, abdominal wounds or skin disorders that may make abdominal massage uncomfortable.

Sites / Locations

  • Glasgow Caledonian University - NMAHP RU

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Optimised bowel care + abdominal massage

Optimised bowel care

Arm Description

In addition to optimised bowel care as described below for the control group, the Intervention Nurse will teach the participant and/or their carer in the intervention arm how to deliver the abdominal massage. This will include viewing the massage DVD and the abdominal massage training booklet, as well as the demonstration of the technique on the participant by the Intervention Nurse.

During a 1 hour outpatient appointment, the participants' existing bowel care routine will be reviewed and optimised. For example, explaining the necessity of adequate fluid intake. No change in medication will be advocated.

Outcomes

Primary Outcome Measures

Change from Baseline to 24 weeks Neurogenic Bowel Dysfunction Score (NBDs)
NBDs is a 10 item questionnaire covering frequency of bowel movements, headache, perspiration or discomfort during defecation; medication for constipation or faecal incontinence; time spent on defecation; frequency of digital stimulation or evacuation; frequency of faecal incontinence; flatus incontinence; and perianal skin problems. Maximum score is 47 with over 14 considered severe.

Secondary Outcome Measures

Neurogenic Bowel Dysfunction Questionnaire (NBD PROM) - change in Score from Baseline to 24 weeks
Constipation Symptoms (Constipation Scoring System (CSS)) - change in Score from Baseline to 24 weeks
Bowel Symptoms (7 day diary) - change in Score from Baseline to 24 weeks
Radio Opaque Marker transit tests - change in Score from Baseline to 24 weeks
One Site only
Adherence to massage schedule (7 day diary) - change in Score from Baseline to 24 weeks
Intervention arm only
Bladder Function (Qualiveen Questionnaire Short Form) - change in Score from Baseline to 24 weeks
Health Status (EQ-5D-5L Health Questionnaire) - change in Score from Baseline to 24 weeks
Change of medication (Concomitant Medication Form)
Patient Resource Questionnaire - cost and use of NHS services (£)
Patient Resource Questionnaire - cost to the patients and their families/carers (£)
Patient Resource Questionnaire - incremental costs, QALYs and incremental cost per QALY derived by the economic model (£)

Full Information

First Posted
May 25, 2016
Last Updated
May 22, 2017
Sponsor
Glasgow Caledonian University
search

1. Study Identification

Unique Protocol Identification Number
NCT03166007
Brief Title
Abdominal Massage for Bowel Dysfunction
Acronym
AMBER
Official Title
Abdominal Massage for Neurogenic Bowel Dysfunction in People With Multiple Sclerosis (AMBER Abdominal Massage for Bowel Dysfunction Effectiveness Research).
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
June 2014 (undefined)
Primary Completion Date
January 2017 (Actual)
Study Completion Date
March 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Glasgow Caledonian University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of the AMBER trial is to determine the effectiveness and cost effectiveness of abdominal massage as part of the adjunct to bowel care in people with Multiple Sclerosis who have problems with their bowel i.e. faecal incontinence and/or constipation.
Detailed Description
Neurogenic bowel dysfunction (NBD: constipation and/or faecal incontinence) is common in people with multiple sclerosis (MS) and is rated as the most severe impact of their disease/injury, above wheelchair dependence. Despite this, current treatment options are limited, poorly evaluated and complex. This research aims to find out whether abdominal massage can help improve the symptoms of NBD in these patients. A small study has already shown that it is possible for patients or carers to perform abdominal massage and in some cases this helped the patient with their symptoms. A larger study is now required to confirm the results one way or another. Patients with Multiple Sclerosis who attend one of the participating study centres who are bothered by constipation and or faecal incontinence will be asked to take part if they fit the other requirements for the trial. Those who agree to take part will be allocated at random to one of two groups, one will receive advice on the management of bowel dysfunction (called optimised bowel care), and the other will receive the same advice and will be taught how to do the abdominal massage (called abdominal massage and optimised bowel care). Both groups will visit a specialist nurse for 1 additional hour after their normal clinical appointment, or at an agreed time, to receive optimised bowel care advice. The patients in the intervention group +/or their carers will receive training on abdominal massage and a DVD/copy of demonstration of the massage for home use. All patients will also be called weekly for 6 weeks to discuss their bowel care. The investigators will measure the results of treatment after 6 and 24 weeks. The investigators are primarily interested in whether patients in the intervention group (receiving optimized bowel care & abdominal massage) have had more of an improvement in their NBD score at 24 weeks after they start the study that the control group (receiving optimized bowel care only). The investigators also want to find out how bad the constipation and bowel symptoms are, how much this affects their life and if they have any problems with their bladder. The investigators will also measure the costs of the treatments and any costs to the patient and their family, and balance these against any benefits of the intervention treatment. During the trial the investigators will assess how well the optimized bowel care and abdominal massage training was delivered by speaking with nurses and listening to recordings of some of the telephone calls. The investigators will talk to the patients to find how they perceive the treatment they received and how they got on during the treatment period and once the treatment finished. The investigators will explore how the treatment delivery and patient's perceptions impact on the patients NBD symptoms. The investigators have worked out from previous research that if 200 patients take part and most complete the trial, there will be enough data to successfully compare the treatments to find out if one is better than the other. Individual participation will be entirely voluntary and the investigators do not believe there are any risks associated with taking part.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
Multiple Sclerosis, Neurogenic Bowel Dysfunction, Abdominal massage

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
191 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Optimised bowel care + abdominal massage
Arm Type
Experimental
Arm Description
In addition to optimised bowel care as described below for the control group, the Intervention Nurse will teach the participant and/or their carer in the intervention arm how to deliver the abdominal massage. This will include viewing the massage DVD and the abdominal massage training booklet, as well as the demonstration of the technique on the participant by the Intervention Nurse.
Arm Title
Optimised bowel care
Arm Type
Active Comparator
Arm Description
During a 1 hour outpatient appointment, the participants' existing bowel care routine will be reviewed and optimised. For example, explaining the necessity of adequate fluid intake. No change in medication will be advocated.
Intervention Type
Behavioral
Intervention Name(s)
Abdominal massage
Intervention Description
The participant should be supine and in a relaxed atmosphere, though this may depend on level of disability. The massage comprises 4 basic strokes (10minutes); Stroking from the small of the back over the iliac crest and down both sides of the pelvis towards the groin; Effleurage follows the direction of the ascending colon across the transverse colon and down the descending colon. This is repeated several times with increasing pressure; Palmar kneading tracks down the descending colon up the ascending colon and down the descending colon once again. Effleurage is repeated and continued with a relaxing transverse stroke over the abdomen; Vibration over the abdominal wall to relieve flatus concludes the massage session. The participants in this group will receive one telephone call per week for 6 weeks and again at 24 weeks to further discuss their bowel management.
Intervention Type
Behavioral
Intervention Name(s)
Optimised bowel care
Intervention Description
During a 1 hour outpatient appointment, the participants' existing bowel care routine will be reviewed and optimised. For example, explaining the necessity of adequate fluid intake. No change in medication will be advocated. The participants in this group will also receive one telephone call per week during the following 6 week period to further discuss their bowel management and again at 24 week time point.
Primary Outcome Measure Information:
Title
Change from Baseline to 24 weeks Neurogenic Bowel Dysfunction Score (NBDs)
Description
NBDs is a 10 item questionnaire covering frequency of bowel movements, headache, perspiration or discomfort during defecation; medication for constipation or faecal incontinence; time spent on defecation; frequency of digital stimulation or evacuation; frequency of faecal incontinence; flatus incontinence; and perianal skin problems. Maximum score is 47 with over 14 considered severe.
Time Frame
Baseline - 24 weeks
Secondary Outcome Measure Information:
Title
Neurogenic Bowel Dysfunction Questionnaire (NBD PROM) - change in Score from Baseline to 24 weeks
Time Frame
Baseline - 24 weeks
Title
Constipation Symptoms (Constipation Scoring System (CSS)) - change in Score from Baseline to 24 weeks
Time Frame
Baseline - 24 weeks
Title
Bowel Symptoms (7 day diary) - change in Score from Baseline to 24 weeks
Time Frame
Baseline - 24 weeks
Title
Radio Opaque Marker transit tests - change in Score from Baseline to 24 weeks
Description
One Site only
Time Frame
Baseline - 24 weeks
Title
Adherence to massage schedule (7 day diary) - change in Score from Baseline to 24 weeks
Description
Intervention arm only
Time Frame
Baseline - 24 weeks
Title
Bladder Function (Qualiveen Questionnaire Short Form) - change in Score from Baseline to 24 weeks
Time Frame
Baseline - 24 weeks
Title
Health Status (EQ-5D-5L Health Questionnaire) - change in Score from Baseline to 24 weeks
Time Frame
Baseline - 24 weeks
Title
Change of medication (Concomitant Medication Form)
Time Frame
Over the study duration (24 weeks)
Title
Patient Resource Questionnaire - cost and use of NHS services (£)
Time Frame
Baseline, 1-6weeks, 12 weeks, 18 weeks and 24 weeks
Title
Patient Resource Questionnaire - cost to the patients and their families/carers (£)
Time Frame
Baseline, 1-6weeks, 12 weeks, 18 weeks and 24 weeks
Title
Patient Resource Questionnaire - incremental costs, QALYs and incremental cost per QALY derived by the economic model (£)
Time Frame
Baseline, 1-6weeks, 12 weeks, 18 weeks and 24 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female over the age of 18 years; Diagnosis of MS (in a stable phase i.e. no MS relapse for 3 months); No major change of medication for 1 month e.g. introduction of disease modifying medications; Individual is bothered by their bowel dysfunction, and; Must not have used abdominal massage for at least 2 months. Exclusion Criteria: Individuals who are unable to undertake the massage themselves or do not have a carer willing to do it; Individuals who are unable to understand the study processes; Individuals who have contraindications to abdominal massage e.g. history of abdominal/pelvic cancer, hiatus, inguinal or umbilical hernia, rectal prolapse, Inflammatory Bowel Disease, pregnancy and past history of volvulus. Recent abdominal scars, abdominal wounds or skin disorders that may make abdominal massage uncomfortable.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Doreen McClurg
Organizational Affiliation
Glasgow Caledonian University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Glasgow Caledonian University - NMAHP RU
City
Glasgow
State/Province
Glasgow city of
ZIP/Postal Code
G4 0BA
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Results will be published, lay summaries produced and massage training guidelines (+DVD) will be made available.
Citations:
PubMed Identifier
30375324
Citation
McClurg D, Harris F, Goodman K, Doran S, Hagen S, Treweek S, Norton C, Coggrave M, Norrie J, Rauchhaus P, Donnan P, Emmanuel A, Manoukian S, Mason H. Abdominal massage plus advice, compared with advice only, for neurogenic bowel dysfunction in MS: a RCT. Health Technol Assess. 2018 Oct;22(58):1-134. doi: 10.3310/hta22580.
Results Reference
derived
Links:
URL
http://www.gcu.ac.uk/amber
Description
Study Website

Learn more about this trial

Abdominal Massage for Bowel Dysfunction

We'll reach out to this number within 24 hrs